There has been considerable progress in the *de novo* design of stable protein structures based on the principle that proteins fold to their lowest free energy state. These efforts have focused on maximizing the free energy gap between the desired structure and all other structures, and have resulted in a wide range of stable proteins that exclusively populate the designed state^[@R1]--[@R4]^. Designing proteins that can switch conformations is more challenging, as multiple states must have sufficiently low free energies relative to the unfolded state, and free energy differences between the states must be small enough that switching can be toggled by an external input^[@R5],[@R6]^. Recent advances in designing systems with multiple states include a transmembrane ion transporter^[@R7]^ and Gβ1 variants that dynamically exchange between two related conformations^[@R8]^; however, a method for the *de novo* design of modular, tunable protein systems that switch conformational states in the presence of an external input has not yet been achieved.

We set out to design *de novo* switchable protein systems guided by the following considerations. First, programming free energy differences between two states is more straightforward in a system governed by inter- and intra-molecular competition at the same site than by allosteric activation at distant sites^[@R9]--[@R11]^ because many of the residue-level interactions can be similar if not identical. Second, a stable protein framework with an extended binding surface available for the competing interactions is more programmable and less likely to engage in off-target interactions than a framework that only becomes ordered upon binding^[@R12],[@R13]^. These features are described by the abstract system in [Fig 1a](#F1){ref-type="fig"}, which undergoes thermodynamically-driven switching between binding-competent and binding-incompetent states. A Latch (blue) contains a peptide sequence (orange) that can bind a Target (yellow) unless blocked by intramolecular interactions to a Cage (cyan); a Key (green) that binds more tightly to the Cage outcompetes the Latch, allowing the peptide to bind the Target. The behavior of such a system is governed by binding equilibrium constants for the individual subreactions ([Fig. 1a](#F1){ref-type="fig"}): K~open~, the dissociation of Latch from Cage; K~LT~, the binding of Latch to Target; and K~CK~, the binding of Cage to Key. When the Latch-Cage interaction is too weak ([Fig. 1b](#F1){ref-type="fig"}, red and orange curves, see [Supplementary Information](#SD6){ref-type="supplementary-material"}), the system binds Target in the presence of little to no Key and the fold induction by Key is low, while when the Latch-Cage interaction is too strong (purple curve), the system only partially binds Target even at high Key concentrations. The Latch-Cage interaction affinity that gives optimal switching ([Fig. 1b](#F1){ref-type="fig"}, blue curve *left*, green curve *right*) is a function of the Latch-Target binding affinity.

LOCKR Design {#S1}
============

To implement the switchable system of [Fig. 1a](#F1){ref-type="fig"}, we chose structural features amenable to tuning the affinities of the Cage-Latch and Cage-Key interactions over a wide dynamic range. Helical interfaces are dominated by sidechain-sidechain interactions, which can be more readily tuned than the backbone hydrogen-bonding interactions between β-strands^[@R14]^. To allow fine control over the specificity and relative affinities of the Cage-Latch and Cage-Key interactions, we chose to design interfaces containing buried hydrogen bond networks; as in DNA base-pairing, specificity can be altered by minor changes to hydrogen bond donors and acceptors^[@R15]^. As a starting point, a designed homo-trimer of -helical hairpins mediated by hydrogen bond networks (5L6HC3_1^[@R15]^) was connected into two monomeric frameworks by designing short unstructured loops between the subunits ([Fig. 1c](#F1){ref-type="fig"}). In the five-helix framework, there is an open binding site for a sixth helix added in trans; this site is filled by a sixth helix in cis in the six-helix framework.

The five-helix (Cage) and six-helix (Cage plus Latch) designs expressed in *E. coli* were largely monomeric by size-exclusion chromatography ([Extended Data 1](#F6){ref-type="fig"}), and remain folded up to 5 M guanidine hydrochloride ([Fig. 1d](#F1){ref-type="fig"}). Small-angle x-ray scattering (SAXS) spectra of the connected designs are similar to that of the starting trimer and indicative of well-folded proteins^[@R16]^ ([Fig. 1e](#F1){ref-type="fig"}, [Supplementary Table 1](#SD5){ref-type="supplementary-material"}; the greater deviations for the five-helix design likely reflects the loss of a helix). The five-helix framework, but not the six-helix framework, bound GFP fused sixth-helix in a pull-down assay ([Fig. 1f](#F1){ref-type="fig"}); the latter result is expected since if the interfaces are otherwise identical and the connecting linker unstrained, the intramolecular interaction should outcompete its intermolecular counterpart because of the reduced entropic cost of formation of intramolecular interactions. To enable the Key to outcompete the Latch, we tuned K~open~ by incorporating mutations in the Latch that weaken its interaction with the Cage^[@R17]--[@R19]^. A Cage-Latch framework with two serine substitutions in the Latch (V223S/I238S) bound Key nearly as strongly as the five-helix Cage without the Latch ([Fig. 1f](#F1){ref-type="fig"}, [Extended Data 2](#F7){ref-type="fig"}); the two serines likely weaken the Cage-Latch interaction by decreasing the helical propensity of the Latch and increasing the cost of desolvating the Latch when it binds the Cage. In the absence of Key, the Latch is bound to the Cage as in the original monomer (their SAXS spectra are nearly identical and closely match those of the design models; [Fig. 1e](#F1){ref-type="fig"}, [Extended Data 1](#F6){ref-type="fig"}), but the guanidine hydrochloride denaturation midpoint and ΔG~folding~ are more similar to the truncated five-helix design indicating the mutations are destabilizing ([Fig. 1d](#F1){ref-type="fig"},[e](#F1){ref-type="fig"}; [Extended Data 1](#F6){ref-type="fig"}). We call such Cage-Latch frameworks Switches, and the Switch-Key pair LOCKR for Latching Orthogonal Cage-Key pRoteins for the remainder of this article.

LOCKR Inducible Bim-Bcl2 Binding {#S2}
================================

We reasoned that a functional peptide sequence embedded in the Latch could be rendered inactive until Key binding frees the Latch from the Cage, and that activation could be tuned by modulating the thermodynamic parameters outlined in [Fig. 1a](#F1){ref-type="fig"}. To install function into LOCKR, we selected the Bim-Bcl2 interaction central to apoptosis as a model system, and sought to cage Bim such that binding to Bcl2 only occurred in the presence of Key. Three Bcl2 binding peptides^[@R20],[@R21]^ ([Extended Data 3a](#F8){ref-type="fig"}) were chosen to sample a range of K~LT~ and the base LOCKR structure was manipulated to sample a range of K~CK~ and K~open~. The three sequences were embedded in the Latch by sampling different helical registers such that residues involved in binding to Bcl2 are sequestered in the Cage-Latch interface ([Extended Data 3b](#F8){ref-type="fig"},[c](#F8){ref-type="fig"}), optimizing for the burial of hydrophobic residues and surface exposure of polar residues. ([Supplementary Information](#SD6){ref-type="supplementary-material"}). To enable sampling of a broader range of K~open~ and K~CK~ values, we expanded the available interaction surface area for the Cage:Latch and Cage:Key interactions by lengthening the helices in the Switch by 5-, 9-, or 18-residues ([Extended Data 3d](#F8){ref-type="fig"}), taking advantage of the modular nature of parametric *de novo* helical bundles^[@R20],[@R22],[@R23]^. Increasing Cage:Latch affinity (decreasing K~open~) makes the system more "off" in absence of Key, and extending the Key to increase affinity for the Cage could allow it to better outcompete the Latch once K~open~ is appropriately tuned (increase K~open~ relative to K~CK~). A design caging full length Bim with Cage, Latch and Key each extended by 18-residues is fully off in the absence of Key ([Fig. 2a](#F2){ref-type="fig"} *left*). Strongest inducible binding was observed with a Latch truncated by 9 residues and a full-length Key ([Fig. 2a](#F2){ref-type="fig"} *right*); the Key buries more surface area and hence outcompetes the Latch for Cage binding. Addition of Key activated Target binding by BimSwitch over forty-fold ([Fig. 2b](#F2){ref-type="fig"}), comparable to or better than naturally occurring protein interaction switches^[@R24]--[@R26]^.

According to the model in [Fig. 1a](#F1){ref-type="fig"}, the range of Key concentrations over which BimSwitch activates is controllable by tuning K~CK~ and K~LT~. We investigated using BLI (Biolayer Interferometry) to monitor binding to Bcl2 in response to different length Keys, hence different K~CK~ ([Fig. 2c](#F2){ref-type="fig"}). These activate BimSwitch at different concentrations: a 40-residue Key produces no activation (pale green), a 45-residue Key activates with an EC~50~ of 230 +/− 58 nM (green), and the full-length 58 residue Key activates with an EC~50~ of 27.0 +/− 2.8 nM (dark green, [Fig. 2b](#F2){ref-type="fig"},[c](#F2){ref-type="fig"}). To probe how LOCKR activation depends on K~LT~, we used different affinity targets: Bcl2, BclB, and Bak bind non-caged Bim with K~d~s of 0.17 nM^[@R21]^, 20 nM^[@R21]^, and 4.2 μM ([Extended Data 4a](#F9){ref-type="fig"}), respectively. Consistent with the [Fig. 1a](#F1){ref-type="fig"} model, activation of BclB binding requires higher Key concentrations than activation of Bcl2 binding, while Bak does not bind in this range of Key concentrations ([Extended Data 4b](#F9){ref-type="fig"}). The equilibria involved in activation are indeed sensitive to small changes in the binding free energy of both Key and Target.

To enable independent caging and specific unlocking of different protein functions in the same cell, we sought to create orthogonal Switch-Key pairs by incorporating different hydrogen bond networks at the Cage-Latch/Key interface through Rosetta design^[@R27],[@R28]^ (see [Supplementary Information](#SD6){ref-type="supplementary-material"}). Designs BimLOCKR~b~ and BimLOCKR~c~ show 22-fold and 8-fold activation with their cognate Keys ([Fig. 2d](#F2){ref-type="fig"}). The original BimLOCKR (BimLOCKR~a~) and the new designs are mutually orthogonal; each Switch is activated only by its cognate Key at concentrations up to 5 μM ([Fig. 2e](#F2){ref-type="fig"}), illustrating the power of the buried hydrogen bond network approach to achieving specificity.

LOCKR inducible protein degradation {#S3}
===================================

We sought to couple Switch activation to protein degradation in living cells by caging the cODC degron^[@R29]^. The caging strategy employed for Bim was used to embed three variants of cODC into Switch~a~: the wild-type sequence, wild-type with a proline removed (since proline destabilizes -helices), and the central dipeptide CA ([Extended Data 5](#F10){ref-type="fig"}). Designs were characterized in *S. cerevisiae* using a dual-inducible expression system^[@R30]^ to independently titrate Switch fused to yellow fluorescent protein (YFP) expression and Key fused to blue fluorescent protein (BFP) expression ([Fig. 3a](#F3){ref-type="fig"}). Key induced degradation was dependent on the presence of the degron in the Switch, and was not observed when YFP was fused to either BimSwitch~a~ or Switch~a~ ([Extended Data 5](#F10){ref-type="fig"}). We optimized the amount of inducible degradation by varying the Switch toehold length to tune K~open~ ([Extended Data 5](#F10){ref-type="fig"}), and found the Switch with proline removed and a 12-residue toehold had the largest dynamic range (hereafter referred to as degronSwitch~a~). Keys of different lengths (43 residues versus 55 residues) produced a similar dynamic range of Switch activation, but a higher Key concentration was required for maximal activation for the shorter Key ([Fig. 3b](#F3){ref-type="fig"}; [Extended Data 6](#F11){ref-type="fig"}), as in the case of BimLOCKR *in vitro* ([Fig. 2d](#F2){ref-type="fig"}), suggesting the [Fig 1a](#F1){ref-type="fig"} model holds in living cells. Key fluorescence was independent of degronSwitch~a~ concentration ([Extended Data 6](#F11){ref-type="fig"}), suggesting the Key is not co-degraded with degronSwitch~a~. We next examined the dynamics of activation, and found that the amount of YFP-degronSwitch~a~ starts decreasing shortly after induction of Key, reaching a new steady-state in \~3 hours ([Fig 3c](#F3){ref-type="fig"}). Taking into account the rates of synthesis ([Supplementary Information](#SD6){ref-type="supplementary-material"}), we estimate a 24 minute half-life for activated degronSwitch~a~, which is similar to the previously measured 11--30 minutes^[@R29]^ for the cODC degron.

We next designed orthogonal degronLOCKRs to enable Key-induced degradation of different proteins in the same cell by installing the proline-removed cODC degron in LOCKR~b~ and LOCKR~c~. YFP fusions of these designs were expressed together with each Key variant fused to cyan fluorescent protein (CFP). degronLOCKR~a~ and degronLOCKR~c~ were strongly activated by their cognate Keys, but not by each other's Key (LOCKR~b~ did not activate; [Extended Data 7](#F12){ref-type="fig"}). To test the orthogonality of degronLOCKRs in the same cell, we constitutively coexpressed degronLOCKR~a~ and degronLOCKR~c~ fused to YFP and red fluorescent protein (RFP), respectively, and titrated expression of each Key. Expression of Key~a~ led to selective degradation of YFP but not RFP, and expression of Key~c~, to selective degradation of RFP but not YFP ([Fig. 3d](#F3){ref-type="fig"}).

To evaluate degronLOCKR function in mammalian cells, we expressed degronSwitch~a~ fused to mCherry RFP in human HEK293T cells, and measured RFP fluorescence in the presence and absence of Key. A redesigned asymmetric degronSwitch~a~ with an 8-residue toehold (see [Supplementary Information](#SD6){ref-type="supplementary-material"}; [Extended Data 8](#F13){ref-type="fig"}) triggered a 11-fold reduction in mean RFP fluorescence in the presence of Key ([Fig. 3e](#F3){ref-type="fig"}).

degronLOCKR control of gene expression in live cells {#S4}
====================================================

We sought to use degronLOCKR to modulate the intracellular concentration of a synthetic transcription factor and dCas9 in yeast. We independently expressed a zinc-finger based synthetic transcription factor (synTF)^[@R31]^ fused to RFP-degronSwitch~a~, and Key~a~-BFP-NLS. Activity of the synTF was measured using YFP produced by the synTF promoter ([Fig. 4a](#F4){ref-type="fig"}, left). Key induction triggered a 61% decrease in RFP (the transcription factor), and an 82% decrease in YFP (the transcription factor target), respectively ([Fig. 4a](#F4){ref-type="fig"}, right; [Extended Data 9a](#F14){ref-type="fig"}). To investigate the generality of transcriptional control by degronLOCKR, an activating dCas9-VP64 fusion^[@R32]^ was fused to RFP-degronSwitch~a~ and targeted to a tet operator site with a constitutively expressed sgRNA to induce expression of YFP ([Fig. 4b](#F4){ref-type="fig"}, left). A 78% reduction of RFP and 41% reduction of YFP was observed upon induction of Key ([Fig. 4b](#F4){ref-type="fig"}, right; [Extended Data 9b](#F14){ref-type="fig"}). Together, these results demonstrate the modularity and functionality of degronLOCKR for controlling the stability of proteins in live cells.

LOCKR inducible nuclear export {#S5}
==============================

To investigate inducible control over nuclear localization, we caged a nuclear export sequence (NES^[@R33]^) in Switch~a~ ([Extended Data 10a](#F15){ref-type="fig"},[b](#F15){ref-type="fig"}) using the same strategy as for Bim and cODC, and fused the resulting nesSwitch~a~ to YFP with a nuclear localization sequence^[@R34]^. An RFP-histone fusion (HTA2) was constitutively expressed in the same yeast cells to act as a nuclear marker ([Fig. 5a](#F5){ref-type="fig"}). YFP co-localized with RFP in the nucleus in the absence of Key~a~-BFP, but upon expression of Key~a~-BFP the YFP fluorescence becomes more cytosolic, likely due to uncaging of the nuclear export signal ([Fig. 5b](#F5){ref-type="fig"}; [Extended Data 10c](#F15){ref-type="fig"}, [d](#F15){ref-type="fig"}).

Next we used nesLOCKR to control the nuclear localization of synTF to modulate its activation of the pSynTF promoter. Using the dual-induction system, we expressed synTF-RFP-nesSwitch~a~ and Key~a~-BFP in the same cell as a pSynTF-YFP reporter, and observed that induction of Key caused a 33% decrease in YFP signal, indicating successful activation of nesLOCKR and exclusion of synTF from the nucleus ([Fig. 5c](#F5){ref-type="fig"}; [Extended Data 10e](#F15){ref-type="fig"}). Together, these results demonstrate our ability to cage different functional peptide motifs in live cells, highlighting the modularity and utility of LOCKR.

Conclusions {#S6}
===========

The design of tunable and generalizable protein switches is a considerable advance for *de novo* protein design. In the switchable LOCKR system described here, a designed key added in trans induces a large conformational change in a designed cage that unlocks protein function. We demonstrate the power and generality of LOCKR by caging three distinct functions: *in vitro*, the proapoptotic peptide Bim binding to Bcl2, and in cells, protein degradation mediated by the cODC degron and protein localization via a nuclear export sequence. The modularity and hyperstability of *de novo* designed proteins enables tuning of Switch activation over a broad dynamic range by modulating the strength of the competing Cage-Key and Cage-Latch interfaces. Moving forward, LOCKR provides a general approach for controlling function that should be applicable to a wide range of proteins and synthetic biology challenges.

It is instructive to compare LOCKR to regulatory systems in nature that utilize autoinhibition and efforts to co-opt those systems for engineered protein switches. Activation of apoptosis by the pro-apoptotic proteins Bak and Bax can be triggered by displacement of auto-inhibitory interactions^[@R35]^, analogous to Key activation in LOCKR. Actin nucleation is modulated by N-WASP, which has an autoinhibited actin nucleating Arp2/3 binding domain that is released upon binding to the activators Cdc42 and PIP2^[@R36]^. A number of proteins, including N-WASP, have been repurposed to control non-cognate functions in a switchable, inducible manner^[@R37],[@R38]^, but the LOCKR system has several advantages. First, LOCKR is a universal platform to cage and then activate functionalities at will ranging from inducible activation of high-affinity protein-protein interactions to controlled degradation or localization of an attached cargo. Second, for any functional modality, many cargoes can be regulated: here we couple key-induced LOCKR-gated degradation to fluorescent protein levels both directly through fusion and indirectly through fusion to an activating transcription factor; kinases can also be controlled in the same way (see accompanying paper). Strategies that rely on repurposing natural proteins have modularity and tunability limited by the evolved functions and ligands of these existing proteins, whereas altering the affinities of LOCKR components is tunable based on simple design principles that are generally irrespective of the functional modality or application. Our use of a toehold for tuning helical displacement is reminiscent of DNA strand displacement technology^[@R39],[@R40]^, but unlike nucleic acid based approaches such as, genetic toggles^[@R41]^, or riboswitches^[@R42],[@R43]^ (which have largely focused on controlling transcription), LOCKR systems can be readily integrated with the many diverse processes controlled by proteins. Viewed in this light, LOCKR brings to proteins the programmability of DNA switching technology, with the added advantages of tunability and flexibility over rewired natural protein systems, and ready interfacing with biological machinery over DNA nanotechnology \[add reference to paper \#2\]. More generally, the domain of sophisticated environmentally sensitive and switchable function no longer belongs exclusively to naturally occurring proteins.

Methods {#S7}
=======

PCR mutagenesis and isothermal assembly {#S8}
---------------------------------------

All primers for mutagenesis were ordered from Integrated DNA Technologies (IDT). Mutagenic primers were designed to anneal \>18bp on either side of the site for mutagenesis with the desired mutation encoded in the primer. PCR was used to create fragments upstream and downstream of the mutation site with \>20bp overlap with the desired pET vector. The resulting amplicons were isothermally assembled into either pET21b, pET28b, or pET29b restriction digested with XhoI and NdeI and transformed into chemically competent *E. coli* XL1-Blue cells. Monoclonal colonies were sequenced with Sanger sequencing. Sequence verified plasmid was purified using Qiagen miniprep kit and transformed into chemically competent *E. coli* BL21(DE3)Star, BL21(DE3)Star-pLysS cells (Invitrogen), or Lemo21(DE3) cells (NEB) for protein expression.

Synthetic gene construction {#S9}
---------------------------

Synthetic genes were ordered from Genscript Inc. (Piscataway, NJ, USA) and delivered in pET 28b+, pET21b+, or pET29b+ *E. coli* expression vectors, inserted at the NdeI and XhoI sites of each vector. For pET28b+ constructs, synthesized DNA was cloned in frame with the N-terminal hexahistidine tag and thrombin cleavage site and a stop codon was added at the C-terminus. For pET21b+ constructs, a stop codon was added at the C-terminus such that the protein was expressed with no hexahistidine tag. For pET29b+ constructs, the synthesized DNA was cloned in frame with the C-terminal hexahistidine tag. Plasmids were transformed into chemically competent *E. coli* BL21(DE3)Star, BL21(DE3)Star-pLysS cells (Invitrogen), or Lemo21(DE3) cells (NEB) for protein expression.

Bacterial protein expression and purification {#S10}
---------------------------------------------

Starter cultures were grown in Lysogeny Broth (LB) or Terrific Broth II (TBII) overnight in the presence of 50 μg/mL carbenicillin (pET21b+) or 30 μg/mL (for LB) to 60 μg/mL (for TBII) kanamycin (pET28b+ and pET29b+). Starter cultures were used to inoculate 500 mL of Studier TBM-5052 autoinduction media containing antibiotic and grown at 37 ℃ for 24 hours. Cells were harvested by centrifugation at 4000 rcf for 20 minutes at 4 ℃ and resuspended in lysis buffer (20 mM Tris, 300 mM NaCl, 20 mM Imidazole, pH 8.0 at room temperature), then lysed by microfluidization in the presence of 1 mM PMSF. Lysates were cleared by centrifugation at 24,000 rcf for at least 30 minutes at 4 ℃. Supernatant was applied to Ni-NTA (Qiagen) columns pre-equilibrated in lysis buffer. The column was washed twice with 15 column volumes (CV) of wash buffer (20 mM Tris, 300 mM NaCl, 40 mM Imidazole, pH 8.0 at room temperature), followed by 15 CV of high-salt wash buffer (20 mM Tris, 1 M NaCl, 40 mM Imidazole, pH 8.0 at room temperature) then 15 CV of wash buffer. Protein was eluted with 20 mM Tris, 300 mM NaCl, 250 mM Imidazole, pH 8.0 at room temperature. Proteins were further purified by gel filtration using FPLC and a Superdex™ 75 Increase 10/300 GL (GE) size exclusion column, pooling fractions containing monomeric protein.

Size-exclusion Chromatography, Multi-Angle Light Scattering (SEC-MALS) {#S11}
----------------------------------------------------------------------

SEC-MALS experiments used a Superdex™ 75 Increase 10/300 GL (GE) size exclusion column connected to a miniDAWN TREOS multi-angle static light scattering and an Optilab T-rEX (refractometer with EXtended range) detector (Wyatt Technology Corporation, Santa Barbara CA, USA). Protein samples were injected at concentrations of 3--5 mg/mL in TBS (pH 8.0). Data was analyzed using ASTRATM (Wyatt Technologies) software to estimate the weight average molar mass (Mw) of eluted species, as well as the number average molar mass (Mn) to assess monodispersity by polydispersity index (PDI) = Mw/Mn.

Circular dichroism (CD) measurements {#S12}
------------------------------------

CD wavelength scans (260 to 195 nm) and temperature melts (25 to 95 ℃) were measured using an AVIV model 420 CD spectrometer. Temperature melts monitored absorption signal at 222 nm and were carried out at a heating rate of 4 ℃/min. Protein samples were at 0.3 mg/mL in PBS pH 7.4 in a 0.1 cm cuvette. Guanidinium chloride (GdmCl) titrations were performed on the same spectrometer with an automated titration apparatus in PBS pH 7.4 at 25 ℃, monitored at 222 nm with protein sample at 0.03 mg/mL in a 1cm cuvette with stir bar. Each titration consisted of at least 40 evenly distributed concentration points with one minute mixing time for each step. Titrant solution consisted of the same concentration of protein in PBS + GdmCl. GdmCl concentration was determined by refractive index.

Small angle X-ray scattering (SAXS) {#S13}
-----------------------------------

Samples were exchanged into SAXS buffer (20 mM Tris, 150 mM NaCl, 2% glycerol, pH 8.0 at room temperature) via gel filtration. Scattering measurements were performed at the SIBYLS 12.3.1 beamline at the Advanced Light Source. The X-ray wavelength (λ) was 1.27 Å and the sample-to-detector distance of the Mar165 detector was 1.5 m, corresponding to a scattering vector q (q = 4π\*sin(θ/λ) where 2θ is the scattering angle) range of 0.01 to 0.59 Å^−1^. Data sets were collected using 34 0.2 second exposures over a period of 7 seconds at 11 keV with protein at a concentration of 6 mg/mL. Data were also collected at a concentration of 3 mg/mL to determine concentration-dependence; all presented data was collected at the higher concentration as no concentration-dependent aggregation was observed. Data from 32 exposures was averaged separately over the Gunier, Parod, and Wide-q regions depending on signal quality over each region and frame. The averages were analyzed using the *ScÅtter* software package to analyze data and report statistics (Extended Data Table 1). *FoXS* was used to compare design models to experimental scattering profiles and calculate quality of fit (*X*) values. The hexahistidine tags and thrombin cleavage sites on the N-termini of LOCKR proteins were modeled using Rosetta Remodel so that the design sequence matched that of the experimentally tested protein. To capture conformational flexibility of these residues, 100 independent models were generated, clustered, and the cluster center of the largest cluster was selected as a representative model for *FoXS* fitting without bias.

GFP pulldown assay {#S14}
------------------

His-tagged LOCKR was expressed per the above protocol from pET28b+ while the Key was expressed fused to superfolder GFP (sfGFP) without a his-tag in pET21b+. The his-tagged LOCKR was purified to completion and dialyzed into TBS (20 mM Tris, 150 mM NaCl, pH 8.0 at room temperature); the Key-GFP remained as lysate for this assay. 100 μL LOCKR at \>1 μM was applied to a 96-well black Pierce® Nickel Coated Plate (ThermoFisher) and incubated at room temperature for 1 hour. Sample was discarded from the plate and washed 3x with 200 μL TBST (TBS + 0.05% Tween-20). 100 μL of lysate containing Key-GFP was added to each well and incubated at room temperature for 1 hour. Sample was discarded from the plate and washed 3x with 200 μL TBST (TBS + 0.05% Tween-20). The plate was washed 1x with TBS, and 100 μL of TBS was added to each well. sfGFP fluorescence was measured on a Molecular Devices SpectraMax M5 plate reader or BioTek Synergy Neo2 plate reader; fluorescence was measured at 485 nm excitation and 530 nm emission, with a bandwidth of 20 nm for excitation and emission.

Bio-Layer Interferometry (BLI) {#S15}
------------------------------

BLI measurements were made on an Octet® RED96 System (ForteBio) with streptavidin (SA) coated biosensors and all analysis was performed within ForteBio Data Analysis Software version 9.0.0.10. Assays were performed with protein diluted into HBS-EP+ Buffer from GE (10 mM HEPES, 150 mM NaCl, 3 mM EDTA, 0.05% v/v Surfactant P20, 0.5% non-fat dry milk, pH 7.4 at room temperature). Biotinylated Bcl2 was loaded onto the SA tips to a threshold of 0.5 nm programmed into the machine's protocol. Baseline was obtained by dipping the loaded biosensors into HBS-EP+ buffer; association kinetics were observed by dipping into wells containing defined concentrations of LOCKR and Key, then dissociation kinetics were observed by dipping into the buffer used to obtain the baseline. Kinetic constants and response at equilibrium were computed by fitting a 1:1 binding model.

Construction of DNA circuits {#S16}
----------------------------

Hierarchical golden gate assembly was used to assemble plasmids for yeast strain construction using the method in Lee et al.^[@R44]^. Individual parts had their BsaI, BsmBI, and NotI cut sites removed to facilitate downstream assembly and linearization. Parts were either generated via PCR or purchased as gBlocks from IDT. These parts were assembled into transcriptional units (promoter-gene-terminator) on cassette plasmids. These cassettes were then assembled together to form multi-gene plasmids for insertion into the yeast genome.

Yeast strains and growth media {#S17}
------------------------------

The base *S. cerevisiae* strain used in all experiments was BY4741 (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0). All yeast cultures were grown in YPD media (10 g/L Bacto Yeast Extract, 20 g/L Bacto peptone, 20 g/L dextrose) or synthetic complete medium (SDC) (6.7 g/L Bacto-yeast nitrogen base without amino acids, 2 g/L complete supplement amino acid mix, 20 g/L dextrose). Selection of auxotrophic markers (URA3, LEU2, and/or HIS3) was performed on synthetic complete medium with the appropriate dropout amino acid mix. All yeast strains used in this work are listed in [Supplementary Table 4](#SD5){ref-type="supplementary-material"} and [5](#SD5){ref-type="supplementary-material"}.

### Estradiol and Progesterone induction {#S18}

Yeast strains were grown overnight by picking a single colony from a plate into YPD media. Saturated culture was diluted 1:500 in fresh SDC and aliquoted into individual wells of a 2 mL 96 well storage block (Corning) for a three hour outgrowth at 30 ℃ and 900 RPM in a Multitron shaker (Infors HT). Estradiol (Sigma-Aldrich) and progesterone (Fisher Scientific) were prepared at a 10x concentration by making the appropriate dilutions into SDC from a 3.6 mM estradiol and 3.2 mM progesterone stock solution. After the three hour outgrowth, 50 μl of estradiol and progesterone inducer were added to the 96 well block in the appropriate combinations and the block was returned to the shaker. Flow cytometry measurement was performed after six hours of incubation for all experiments, except for those involving synTF or dCas9, which was allowed to incubate for 12 hours due to the additional transcriptional step in the system.

Mammalian Cell Culture and Lentiviral Transduction {#S19}
--------------------------------------------------

HEK293T cells (from ATCC® CRL-3216™) were maintained in DMEM (Dulbecco's Modified Eagle Medium, Gibco) supplemented with 10% Fetal Calf Serum (SAFC) and passaged every \~3 days. Cell line was not authenticated nor tested for mycoplasma contamination. Pantropic VSV-G pseudotyped lentivirus was produced via transfection of Lenti-X 293T cells (Clontech \#11131D) with a custom pHR'SIN:CSW transgene expression vector and the viral packaging plasmids pCMVdR8.91 and pMD2.G using Fugene HD (Promega). At 48 hr, viral supernatant was harvested and the HEK293T cells were exposed to the virus for 24 hr. Transductions were performed in triplicate. All plasmids used for HEK293T experiments are listed in [Supplementary Table 6](#SD5){ref-type="supplementary-material"}.

Description of automated flow cytometry and continuous culture system {#S20}
---------------------------------------------------------------------

### Hardware {#S21}

We adapted an existing automated experimental platform^[@R45]^ to perform variable concentration small molecule induction and long-term culturing. Yeast cultures were grown in 50 mL optically clear conical tubes (Falcon) that were held in eight custom temperature-controlled, magnetically stirred chambers. Liquid handling was accomplished using a 14 position stream selector (VICI Cheminert) and two syringe pumps (Cavro XCalibur Pump, TECAN) of a BD High-Throughput Sampler. Commands to the HTS were controlled using LABVIEW 2013. This setup allowed for periodic sampling and dilution of individual cultures. Each sampling period consisted of three main steps: 1) send sample to flow cytometer for measurement, 2) extract culture and send to waste, and 3) replenish culture with fresh media at desired hormone concentration. Each sampling period can be designated to either induce cultures to a new higher hormone concentration or to maintain desired hormone concentration. A sampling frequency of 24 minutes and a dilution volume of 3 mL were used.

### Yeast culture {#S22}

Yeast strains were grown overnight by picking a single colony from a plate into YPD media. Saturated culture was diluted 1:200 into fresh SDC. Cultures were grown for 2 hours in glass tubes at 30 ˚C and 250 RPM in a Innova 44 shaker (New Brunswick). Cultures were then diluted to 0.01 OD~600~ in fresh SDC and aliquoted into individual 50 mL optically clear conical tubes (Falcon) at a total volume of 30 mL YPD. Another one hour outgrowth was performed in bioreactors with magnetically-controlled stir bars at 30 ˚C. All SDC media was supplemented with 5,000 U/mL Penicillin Streptomycin (Thermo-Fisher).

### Estradiol and progesterone induction to test degronLOCKR dynamics {#S23}

A 1X concentration was determined by the highest desired hormone concentration at which to test strains (30 nM E2 and 50 nM Pg, respectively). A solution of E2 and SDC media was created at a 10X concentration to bring pre-induced cultures to a desired concentration in one sampling period. A second solution of Pg and SDC media was created at a 10X concentration to induce Key expression after degSwitch-YFP expression reached steady-state. SDC media was prepared at three different concentrations of hormone: (1) 10X E2/no Pg, (2) 1X E2/no Pg, (3) 1X E2/10X Pg, and (4) 1X E2/1X Pg. After a one hour outgrowth in bioreactors (t=−6 hr), the first induction was performed to achieve E2 concentration by extracting 3 mL from all cultures and replenishing with (1). After E2 induction, sampling proceeded as described above (see [Hardware](#S22){ref-type="sec"}*)*. All sampling periods following the first induction time point included sending a sample to the cytometer for measurement, extracting 3 mL from all cultures, and replenishing cultures with (2). During the second induction time point (t=0 hr), cultures were induced with (3) to activate Key expression. This induction was followed by the same procedure as the first induction, except that hormone concentrations were maintained by (4). Controls (no activated Key expression) did not undergo a second induction and, instead, continued to be replenished by (2).

Flow cytometry {#S24}
--------------

### Yeast experiments {#S25}

Analysis of fluorescent protein expression was performed using a BD LSRII flow cytometer (BD Biosciences) equipped with a high-throughput sampler. Yeast cultures were diluted in TE before running through the instrument to obtain an acceptable density of cells. YFP (Venus) fluorescence was measured using the FITC channel, RFP (mScarlet) was measured using the PE-Texas Red channel, and BFP (mTagBFP2) was measured using the DAPI channel. For steady-state measurements, 5,000--10,000 events were collected per sample. For dynamic measurements, 2,000--10,000 events were collected per sample. Fluorescence values were calculated as the height (H) measurement for the appropriate channel and normalized to cell size by dividing by side scatter (SSC-H). All analysis of yeast flow cytometry data was performed in Python 2.7 using the package FlowCytometryTools v0.5.0 and custom scripts.

### HEK293T experiments {#S26}

Analysis of fluorescent protein expression was performed using a BD Fortessa flow cytometer (BD Biosciences) equipped with a high-throughput sampler. Cells were harvested and washed twice in PBS before running through the instrument in PBS+5% FBS. RFP (mCherry) fluorescence was measured using the PE-CF594 channel and BFP (tagBFP) was measured using the BV 421 channel. 50,000 events were collected per sample. Live cells were gated according to FSC-A and SSC-A, and singlets were gated according to SSC-A and SSC-H. Analysis of HEK293T flow cytometry data was performed using FlowJo v10.

Fluorescence microscopy {#S27}
-----------------------

Saturated culture was diluted 1:100 in fresh SC media followed by a 3 hour outgrowth at 30 ℃ with shaking at 700 RPM in a Multitron shaker (Infors HT). Estradiol (Sigma-Aldrich) and progesterone (Fisher Scientific) were prepared at a 20x concentration by making the appropriate dilutions into SC media from a 3.6 mM estradiol and 3.2 mM progesterone stock solution. Cells were induced with estradiol and/or progesterone at a final concentration of 200 μM and 250 μM, respectively. After 8 hours of growth, cells were resuspended in 1x PBS and imaged on a Zeiss Axio Observer Z1 microscope with X-Cite Series 120 fluorescent lamp and Hamamatsu Orca-Flash 4.0 Digital Camera.

Structural visualization and figures {#S28}
------------------------------------

All structural images for figures were generated using PyMOL^[@R46]^.

Extended Data {#S29}
=============

![Biophysical data from LOCKR design.\
**a)** Size Exclusion Chromatography for the Monomer, Truncation, and LOCKR designs on Superdex 75. Peaks indicated by vertical dashed lines represent monomeric protein used in downstream characterization and functional assays. SEC repeated three times with similar results. **b)** Circular dichroism spectroscopy to determine protein stability upon heating and chemical denaturant, guanidinium chloride. Top row: full wavescan at 25°C (blue), 75°C (orange), 95°C (red), then cooled to 25°C (cyan). Middle row: guanidinium chloride melts also shown overlapped in [Figure 1d](#F1){ref-type="fig"}. Bottom row: fraction folded was converted to equilibrium constant, then to ΔG~unfolding~ value. The linear unfolding region, marked by vertical lines in middle row, was fit to determine the ΔG~folding~ for each design. Repeated four times with similar results. **c)** SAXS spectra (black) referenced in [Figure 1e](#F1){ref-type="fig"} fit to Rosetta design models (red) using FoXS with chi-values referenced in the upper right.](nihms-1532383-f0006){#F6}

![GFP pulldown assay finds mutations for LOCKR.\
Different putative LOCKR constructs were adhered via 6x-His tag to a Ni coated 96-well plate, Key-GFP was applied, and excess washed. Resulting mean fluorescence values represent Key-GFP bound to LOCKR constructs. The truncation was used as a positive control, since the Key binds to the open interface. The monomer as a negative control since it does not bind the Key. Error bars represent the standard deviation of three technical replicates, because Key-GFP was not purified from bacterial lysate leading to minor technical variability.](nihms-1532383-f0007){#F7}

![Caging Bim-related sequences.\
**a)** Three Bcl2 binding sequences were grafted onto the Latch. aBcl2 is a single helix from a designed Bcl2 binder (pdb: 5JSN) where non Bcl2-interacting residues were reverted back to the standard LOCKR Latch sequence, shown as dashes. pBim is the partial Bim sequence where only Bcl2-interacting residues are grafted onto the Latch. Bim is the full consensus sequence of the BH3 domain. **b)** LOCKR (left) with the Latch in dark blue. The helical Bim sequence is taken from the Bim/Bcl2 interaction and grafted onto the Latch **c)** Left: Bcl2 (tan) binding to Bim (orange) from pdb:2MV6 with pBim residues shown as sticks. Center: a well caged graft where important binding residues are caged. Right: a poor graft where Bcl2 binding residues are exposed and polar surface residues are against the Cage interface. **d)** Tuning BimLOCKR. aBcl2, pBim, and Bim were caged to varying degrees of success. Early versions of the switch, with aBcl2 and pBim did not efficiently cage Bcl2 binding in the off state. They also only weakly bound the Key leading to small dynamic range. The Cage and Key was extended by 5, 9, and 18 residues in an attempt to provide a larger interface to tightly hold the Latch in the off state and provide a larger interface for Key binding to increase the dynamic range of activation. Mutations on the Latch, identified in [Extended Data 2](#F7){ref-type="fig"}, and providing toeholds for Key binding were the two strategies employed to tune the switch. In graphs, "off" refers to 250--310 nM switch an absence of Key while "on" refers to excess Key added. The height of the bar graph shows the R~eq~ as measured by Bio-layer interferometry.](nihms-1532383-f0008){#F8}

![Validation of model in [Figure 1a](#F1){ref-type="fig"}.\
**a)** Measurement of Bim:Bak affinity. Bio-layer interferometry (BLI) at three concentrations gives on and off rates for Bim:Bak binding, yielding the constants shown on right. Mean shown with standard deviation of four technical replicates to account for variablility in drift on the BLI instrument. **b)** BLI measurement of BimLOCKR~a~ (400 nM) binding to Bcl2 (gold), BclB (yellow), and Bak (lighter yellow - BimLOCKR at 1 μM) as Key is added to solution. Normalized due to differences in R~max~ for Bcl2 and BclB on the tip. **c)** BLI measurement of BimLOCKR~a~ binding to Key~a~ immobilized on the tip. Open circles are with no Bcl2 present, gold points are with Bcl2 present at 500 nM.](nihms-1532383-f0009){#F9}

![Caging cODC sequences.\
**a)** Three variations of the cODC degron to Cage. Variations meant to tune K~open~ by removing the destabilizing proline (noPro) and minimizing mutations to the Latch (CA only). **b)** Predicted models of the full and noPro cODC sequences (orange) threaded onto the Latch (dark blue). Thread position chosen such that the cysteine residue needed for degradation is sequestered against the Cage (light blue). Proline highlighted in red in the full cODC mutated to an isoleucine in the noPro variant. **c)** Comparing the stability of YFP fused to cODC variants caged in Switch~a~ to an empty Switch~a~ and to bimSwitch~a~. The dual-inducible system from [Fig 3a](#F3){ref-type="fig"} was used to express the various YFP-Switch~a~ fusions (solid lines and dots) via pGAL1 and E2, and Key~a~-BFP via pZ3 and Pg. YFP (Venus) alone, YFP fused to the WT cODC (cODC) or YFP fused to the proline removed cODC (cODC noPro), were also expressed using pGal1 and E2 (dashed lines). Cells were induced with a saturating dose of E2 (50 nM) and Pg was titrated in from 0--200 nM. Fluorescence was measured at steady-state using a flow cytometer; data represent mean ± s.d. of three biological replicates. Lines connecting data are a guide to the eye. A moderate decrease in YFP fluorescence was observed as a function of Pg for the full cODC variant, whereas only a small decrease was observed for the proline removed and CA only. No decrease in fluorescence was observed as a function of Key induction for YFP alone, empty Switch~a~, or bimSwitch~a~. **d)** Tuning toehold lengths of degronLOCKR~a~. The dual-inducible system from [Fig 3a](#F3){ref-type="fig"} was used to express the various YFP-Switch~a~ fusions via pGal1 and E2, and Key~a~-BFP via pZ3 and Pg. YFP fused to the proline-removed cODC (cODC no Pro) was also expressed using pGal1 and E2 (dashed line). Cells were induced with a saturating dose of E2 (50 nM) and Pg was titrated in from 0--200 nM. Fluorescence was measured at steady-state using a flow cytometer; data represent mean ± s.d. of three biological replicates. Lines connecting data are a guide to the eye. (Left) cODC variants alone to show dynamic range of Full cODC. (Right) Extending toehold on proline-removed version from 9 to 12 and 16aa. Proline-removed with 12aa toehold shows the greatest dynamic range of all the Switches tested.](nihms-1532383-f0010){#F10}

![YFP (a) and BFP (b) expression corresponding to [Fig 3b](#F3){ref-type="fig"}.\
0--50nM E2 and 0--200nM Pg were used to induce expression of YFP-degronSwitch~a~ and Key~a~ (Full-length or truncated)-BFP, respectively. Fluorescence was measured at steady-state using a flow cytometer. Heatmaps depict mean fluorescence and are a representative sample of three biological replicates. E2 dose (50nM) depicted in [Fig 3b](#F3){ref-type="fig"} is indicated with the black rectangle on the heatmaps. YFP fluorescence was normalized to the maximum fluorescence (50nM E2, 0nM Pg). BFP expression was not dependent on expression of the Switch, suggesting the Key does not co-degrade with the Switch.](nihms-1532383-f0011){#F11}

![degronLOCKR~a-d~ orthogonality.\
All combinations of pTDH3-YFP-degronSwitch and pTDH3-Key-CFP were tested. Fluorescence was measured at steady-state using a flow cytometer. YFP fluorescence was averaged across three biological replicates. Percentage degradation was calculated by subtracting the mean YFP-degronSwitch fluorescence with the given Key-CFP coexpressed from the YFP-degronSwitch fluorescence without any Key expressed and normalizing by the YFP-degronSwitch fluorescence without any Key expressed. degronSwitch~a~ is activated strongly by Key~a~ and weakly by Key~b~. degronSwitch~c~ is activated strongly by Key~c~ and weakly by Key~b~. Because degronSwitch~a~ and degronSwitch~c~ are not activated by Key~c~ and Key~a~ respectively, we consider these two to be an orthogonal pair.](nihms-1532383-f0012){#F12}

![Comparison of different degronSwitch variants in HEK293T cells.\
Fluorescence of RFP-degronSwitch variants in the presence and absence of Key-BFP were measured using flow cytometry. Original symmetric design was compared against a new asymmetric design. Two toehold lengths were tested for each variant. Data in bar graph represents geometric mean ± s.d. of three biological replicates. Histograms are depicted for a representative sample. Asymmetric cage with a t8 toehold demonstrates the largest dynamic range.](nihms-1532383-f0013){#F13}

![YFP and RFP expression for synTF (a) and dCas9-VP64 (b)\
assay corresponding to [Fig 4](#F4){ref-type="fig"} as a function of E2 (0--125 nM) and Pg (0--100 nM). YFP fluorescence represents transcriptional output of either synTF or dCas9-VP64 and RFP fluorescence represents fluorescence of either synTF or dCas9-VP64. Fluorescence was measured at steady-state using flow cytometry. Heatmaps depict mean fluorescence and are a representative sample of three biological replicates. E2 dose (31.25nM) depicted in [Fig 5](#F5){ref-type="fig"} is indicated with the black rectangle on the heatmaps.](nihms-1532383-f0014){#F14}

![Design and characterization of nesLOCKR.\
**a)** NES used in this report. **b)** The NES (orange) caged on the helical Latch (dark blue, cartoon) with hydrophobic residues sequestered against the Cage (light blue, surface) **c)** (Left) Schematic of cytosolic YFP-nesSwitch~a~ and Key-BFP with nuclear marker HTA2-RFP. (Right) YFP fluorescence shows the expected cytosolic distribution when YFP-nesSwitch~a~ is expressed with no NLS (left) but punctae of YFP fluorescence is observed when both YFP-nesSwitch~a~ and Key-BFP are expressed in the cytosol, which we assume is due to aggregation of the nesSwitch~a~. Key-BFP fluorescence is co-localized to YFP-nesSwitch~a~ fluorescence. **d)** (Left) Schematic of NLS-YFP-nesSwitch~a~ with Key-BFP-NLS with nuclear marker HTA2-RFP. (Right) YFP-nesSwitch~a~ is localized to the nucleus when expressed with the strong (SV40) NLS. When Key-BFP is expressed with a moderately strong NLS, the same pattern of cytosolic YFP punctae formation is observed as when Key-BFP is expressed without a NLS ([Figure 5b](#F5){ref-type="fig"}), indicating that uncaging of the NES is independent of NLS on Key-BFP localization. Key-BFP-NLS fluorescence is co-localized to NLS-YFP-nesSwitch~a~ fluorescence **e)** YFP and RFP expression for synTF assay corresponding to [Fig 5c](#F5){ref-type="fig"} as a function of E2 (0--125 nM) and Pg (0--500 nM). Fluorescence was measured at steady-state using flow cytometry. Heatmaps depict mean fluorescence and are a representative sample of three biological replicates. E2 dose (31.25nM) depicted in [Fig 5c](#F5){ref-type="fig"} is indicated with the black rectangle on the heatmaps.](nihms-1532383-f0015){#F15}
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Code Availability

Python scripts, bash scripts, and Rosetta Design XMLs are available for download at <https://github.com/BobbyLangan/DeNovoDesignofBioactiveProteinSwitches>

Data Availability

The authors declare that all data supporting the findings of this study are available within the paper (and its [Supplementary Information](#SD6){ref-type="supplementary-material"} files), but original data that supports the findings are available from the corresponding authors upon reasonable request. Plasmids encoding LOCKR scaffolds (non-functional Switches and Keys), BimLOCKR, degronLOCKR, and nesLOCKR can be found on Addgene (plasmids 127416--127424, 127200--127206 and 127246).

![Design of the LOCKR system.\
**a,** The Switch, composed of a Cage (cyan) and Latch (blue) with a functional motif (orange), has a thermodynamic transition to the open state able to bind Key (green) or Target (yellow). **b,** Numerical solutions of the model in (a) for different values of K~LT~ (1 nM, left; 50 nM, right) and K~open~ (0.1, red; 0.001, orange; 1e-5, green; 1e-7, blue; 1e-9, purple) with K~CK~ fixed at 1 nM. **c,** Conversion of 5L6HC3 to monomeric frameworks. In LOCKR (right), the double mutant V223S/I238S allows the Key to bind. **d,** Guanidinium chloride denaturation of trimer (dark blue), monomer (cyan), truncated five-helix framework (red), and LOCKR (green) monitoring mean residue ellipticity (MRE) at 222 nm. Repeated 3 times with similar results. **e,** Small-angle X-ray scattering (SAXS) Kratky plots for the monomeric frameworks are similar to that of the input trimer, with the greatest deviation for the five-helix framework. Colors continued from (d). **f,** Key-GFP was added to monomeric frameworks immobilized onto a plate via a hexahistidine tag; after washing, binding was measured by GFP fluorescence (mean of n=3 technical replicates, error bars indicate s.d).](nihms-1532383-f0001){#F1}

![BimLOCKR design and activation.\
**a,** Bio-layer interferometry (BLI) measurement of BimLOCKR (250 nM) binding to immobilized Bcl2 in the presence and absence of 5 µM Key. Bim is tightly caged in the absence of Key; introduction of the toehold (right) allows key to outcompete Latch leading to Bcl2 binding. **b,** BLI measurement of Key-dependent binding of 250 nM BimLOCKR to Bcl2. Purple is 3 µM Key, then a three-fold dilution of the Key through blue, cyan, green, yellow, and orange; control without Key in red. **c,** Bcl2 binding by BimLOCKR as a function of Key concentration. BLI data was fit for the different length Keys to obtain equilibrium sensor response. BLI experiments (b,c) repeated three times with similar results. **d,** Bcl2 binding of BimSwitch~a~ (dark blue), BimSwitch~b~ (blue), and BimSwitch~c~ (light blue) designs in response to cognate Key, measured by BLI and normalized to R~max~. Repeated twice with similar results. **e,** Bcl2 binding in BLI experiments for each Switch at 250 nM, Key at 5 µM; data points are average R~max~ of two replicates.](nihms-1532383-f0002){#F2}

![Testing functionality of degronLOCKR in live cells.\
**a,** Dual-induction system used in *S. cerevisiae* to test degronLOCKR function. **b,** Dose response of YFP-degronSwitch~a~ and Key~a~-BFP at 50nM E2 as a function of Pg induction. YFP, normalized to no Pg; BFP normalized to max Pg. Lines connecting data are a guide to the eye. **c,** Dynamics of degronLOCKR using an automated flow cytometry platform. Cells were grown to steady-state at 50nM E2 then induced with Pg to express Key~a~-BFP at t~0hrs~. Lines represent moving average taken over three data points. **d,** Dose response of orthogonal degronLOCKRs as a function of Pg. YFP-degronSwitch~a~ and RFP-degronSwitch~c~ were expressed constitutively in the same cell with either Key~a~-BFP (left) or Key~c~-BFP (right) expressed using Pg. YFP-degronSwitch~a~, RFP-degronSwitch~c~ and either Key~a~-BFP or Key~c~-BFP were normalized to no Pg (RFP, YFP) or max Pg (BFP). Lines connecting data are a guide to the eye. **e,** Asymmetric RFP-degronSwitch~a~ was expressed in HEK293T cells with and without Key. Flow cytometry distribution of RFP fluorescence for a representative sample indicates decreased RFP expression in the presence of Key. Geometric mean of RFP expression is quantified in the bar plot. Data in all panels represent mean ± s.d. of three biological replicates.](nihms-1532383-f0003){#F3}

![Controlling gene expression using degronLOCKR in yeast.\
**a,** (Left) Dual-induction system used to determine the effect of degronLOCKR~a~ on a synthetic transcription factor (synTF). (Right) Dose response of YFP, SynTF-RFP-degronSwitch~a~ and Key~a~-BFP-NLS at 31.25nM E2 as a function of Pg induction, normalized to no Pg (YFP, RFP) or max Pg (BFP). **b,** (Left) Dual-induction system used to determine the effect of degronLOCKR~a~ on a dCas9-VP64 targeted to the pTet7x promoter. (Right) Dose response of YFP, dCas9-VP64-RFP-degronSwitch~a~ and Key~a~-BFP-NLS at 31.25 nM E2 as a function of Pg induction, normalized to no Pg (YFP, RFP) or max Pg (BFP). Data in all panels represent mean ± s.d. of three biological replicates. Lines connecting data are a guide to the eye.](nihms-1532383-f0004){#F4}

![Controlling protein localization using nesLOCKR in yeast.\
**a,** Key-induced nuclear export of NLS-YFP-nesSwitch~a~. The nucleus is marked by the histone HTA2-RFP. **b,** Fluorescence microscopy showing co-localization of NLS-YFP-nesSwitch~a~ (green) with nuclear HTA2-RFP (red) fluorescence when no Key~a~-BFP is expressed (top), compared to a more diffuse NLS-YFP-nesSwitch~a~ fluorescent signal observed outside of the nucleus when Key~a~-BFP is expressed (bottom). Images shown are representative of n=3 biological replicates. **c,** (Left) Dual-induction system used to determine the effect of nesLOCKR~a~ on a synthetic transcription factor (synTF). (Right) Dose response of YFP, synTF-RFP-nesSwitch~a~ and Key~a~-BFP at 31.25 nM E2 as a function of Pg induction, normalized to no Pg (RFP, YFP), maximum Pg (BFP). Data represent mean ± s.d. of three biological replicates. Lines connecting data are a guide to the eye.](nihms-1532383-f0005){#F5}
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